A detailed history of Opinicus Capital, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Opinicus Capital, Inc. holds 3,987 shares of NVO stock, worth $416,880. This represents 0.38% of its overall portfolio holdings.

Number of Shares
3,987
Previous 4,812 17.14%
Holding current value
$416,880
Previous $687 Million 30.88%
% of portfolio
0.38%
Previous 0.58%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$119.07 - $145.42 $98,232 - $119,971
-825 Reduced 17.14%
3,987 $475 Million
Q2 2024

Jul 22, 2024

SELL
$122.71 - $146.91 $736 - $881
-6 Reduced 0.12%
4,812 $687 Million
Q1 2024

Apr 16, 2024

BUY
$102.11 - $135.92 $491,965 - $654,862
4,818 New
4,818 $619 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $236B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Opinicus Capital, Inc. Portfolio

Follow Opinicus Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opinicus Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opinicus Capital, Inc. with notifications on news.